Family Medicine Doctors in Rochester, MI Accepting Medicare

26 Family Medicine doctors found. Showing 21 - 26

Frederick Charles Rosin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 W University Dr, Ste 250, Rochester, MI 48307 Phone: 248-650-6301    Fax: 248-650-5486

Dr. Seth Aborhey, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr # 3-n, Crittenton Hospital, Department Of Family Medicine, Rochester, MI 48307 Phone: 248-601-4900

Dr. Blake Terrance Pearson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr Ste 250, Rochester, MI 48307 Phone: 248-650-6301

Dr. Ryan Pradko, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 W University Dr Ste 225, Rochester, MI 48307 Phone: 248-824-2570    Fax: 248-824-2571

Patricia Brooks, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr, Suite 250, Rochester, MI 48307 Phone: 248-650-6301    Fax: 248-650-5486

Dr. Marco Antonio Peterson Jr., M.D., M.S. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, 2 South, Rochester, MI 48307 Phone: 786-340-3804

News Archive

Positive results from Merck's Phase IIB clinical study of odanacatib for treating osteoporosis

New data from a Phase IIB clinical study of odanacatib, Merck & Co., Inc.'s oral, once-weekly investigational treatment for osteoporosis, showed that when stopping treatment after two years, the increases in lower back (lumbar spine) bone mineral density (BMD) were reversed over the next year, while BMD at the hip (femoral neck) remained above levels observed at the start of the study.

BioCision announces ThawSTAR™ automated sample thawing system

BioCision, LLC, a leader in advanced products to improve biospecimen handling and standardization, today announced the availability of ThawSTAR™ automated sample thawing system, a breakthrough technology that addresses the "last mile" in the cryopreservation process. Utilizing the patent-pending STAR™ adaptive sensing technology for rapid and standardized thawing and recovery of cells and other biospecimens, ThawSTAR system tailors the thaw cycle to the specific characteristics of each frozen sample.

VIDA Diagnostics gains FDA approval for comprehensive lung analysis software

VIDA Diagnostics Inc. announced today that its primary product, Pulmonary Workstation 2.0 (PW2) has obtained FDA 510(k) clearance for sale.

FDA clears Curemark's CM – 4612 IND for Phase III clinical trial in ADHD

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)